BioWorld MedTech

June 2, 2010

Deals roundup: Covidien to pay $2.6 billion for ev3, sell sleep business

In an effort to boost its presence in the vascular market, Covidien (Dublin, Ireland) said Tuesday it would buy ev3 (Plymouth, Minnesota) for $22.50 a share in cash, or $2.6 billion. (Medical Device Daily) Read More

St. Jude Medical reinvigorates its cardiovascular business

Washington roundup: FDA again claims authority over drugs-of-abuse test kits

International report: Elekta acquires Resonant Medical for $30M in cash

Financings roundup: National Health Investors in $20M funding accord with CFG

MDD's food for med tech thought

Agreements/contracts: Naples Diagnostic to use IntelePACS mammography

Court report: Applied gets settlement against false advertising

Med-Tech Notes

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...